Divestment15 Aug 2026, 09:30 am
RPG Life Sciences Completes API Business Transfer to Subsidiary
AI Summary
RPG Life Sciences Ltd has announced the completion of transactions related to the Business Transfer Agreement (BTA) for its Active Pharmaceuticals Ingredients (API) business. The API business has been transferred to RPG Active Pharma Limited, a wholly-owned subsidiary. The transfer is effective from August 15, 2026. This move is part of the company's strategic restructuring and aims to streamline operations within its pharmaceutical segment.
Key Highlights
- API business transferred to wholly-owned subsidiary, RPG Active Pharma Limited.
- Transaction completion effective from August 15, 2026.
- Company previously announced execution of the Business Transfer Agreement.
- This is a strategic move to streamline business operations.
Price Impact
More from RPGLIFE